Company Presentation • 15 Jul 2024 20:00
Corporate presentation
No more presentations
𝛼SK or SearchENTITY
Kolon TissueGene (950160 KS)
Kolon TissueGene (950160 KS)
16
Analysis
Health Care • United States
Kolon TissueGene, Inc. operates as a biopharmaceutical company. The Company develops novel advanced orthopedic disorders cell therapies, novel cell and gene therapies drugs, and other related products. Kolon TissueGene offers services worldwide.
morex